Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. DTCA/I, consumer secondary audience
  4. 393 - I am curious to know how/why the product ColdFX can make DTC claims such as 'clinically proven' and '#1 doctor recommended'. Would this not fall under the NHP regulations of PAAB?
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

393 - I am curious to know how/why the product ColdFX can make DTC claims such as 'clinically proven' and '#1 doctor recommended'. Would this not fall under the NHP regulations of PAAB?

Scheduled Pinned Locked Moved DTCA/I, consumer secondary audience
1 Posts 1 Posters 233 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    Thanks for your question. There is an important distinction to make here with regards to the Canadian regulatory landscape for drug advertising. The PAAB code applies to health care product advertising which is directed to healthcare professionals. Natural Health Products (NHPs) are indeed included in the PAAB code’s definition of health care products (PAAB s1 & 11); however, DTC for NHPs falls neither within the scope of the PAAB code nor within the scope of PAAB review activities. As a courtesy, concerns relating to NHP DTC advertising may be directed to Advertising Standards Canada, MIJO, or Health Canada. The scope of the PAAB includes promotional healthcare product communication for prescription, non-prescription, biological and natural health products to health care professionals in all media. PAAB also provides advisory comments on direct-to-consumer materials for prescription drugs. You can learn more about the PAAB vision, mission, mandate, and scope at the following link: http://www.paab.ca/mission.htm

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups